Table 2.
Risk factors associated with the presence of NAFLD.
| Variables | β | SE | Wald χ 2 | P value | OR (95% CI) |
|---|---|---|---|---|---|
| Age (year) | 0.018 | 0.002 | 59.47 | <0.001 | 1.018 (1.014-1.023) |
| Body mass index (kg/m2) | 0.367 | 0.012 | 690.14 | <0.001 | 1.443 (1.409 – 1.478) |
| Glutamic-pyruvic transaminase (U/L) | 0.044 | 0.004 | 154.629 | <0.001 | 1.045(1.037-1.052) |
| Glutamic oxaloacetic transaminase (U/L) | -0.032 | 0.005 | 38.155 | <0.001 | 0.969(0.959-0.978) |
| Alkaline phosphatase (U/L) | 0.003 | 0.001 | 4.013 | 0.045 | 1.003(1.000-1.005) |
| γ-Glutamyltransferase (U/L) | 0.003 | 0.001 | 12.842 | <0.001 | 1.003(1.002-1.005) |
| Total bilirubin (μmol/L) | 0.016 | 0.005 | 9.534 | 0.02 | 1.016(1.006-1.027) |
| Triglycerides (mmol/L) | 0.400 | 0.036 | 125.433 | <0.001 | 1.492(1.391-1.601) |
| HDL cholesterol (mmol/L) | -0.871 | 0.117 | 55.335 | <0.001 | 0.419(0.333-0.527) |
| Fasting plasma glucose (mmol/L) | 0.196 | 0.028 | 48.178 | <0.001 | 1.217(1.151-1.286) |
| Serum uric acid (umol/L) | 0.005 | 0.000 | 120.929 | <0.001 | 1.005(1.004-1.006) |
β: partial regression coefficient; SE: standard error of partial regression coefficient; OR: odds ratio; CI: confidence interval; HDL: high-density lipoprotein.